Cargando…
Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study
BACKGROUND: The treatment for the eradication of Helicobacter pylori (H. pylori) is complex; full effectiveness is rarely achieved and it has many adverse effects. In developing countries, increased resistance to antibiotics and its cost make eradication more difficult. Probiotics can reduce adverse...
Autores principales: | Navarro-Rodriguez, Tomás, Silva, Fernando Marcuz, Barbuti, Ricardo Correa, Mattar, Rejane, Moraes-Filho, Joaquim Prado, de Oliveira, Maricê Nogueira, Bogsan, Cristina S, Chinzon, Décio, Eisig, Jaime Natan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614530/ https://www.ncbi.nlm.nih.gov/pubmed/23530767 http://dx.doi.org/10.1186/1471-230X-13-56 |
Ejemplares similares
-
Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial
por: Eisig, Jaime Natan, et al.
Publicado: (2015) -
Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers
por: Silva, Fernando Marcuz, et al.
Publicado: (2015) -
Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy
por: Silva, Fernando M, et al.
Publicado: (2008) -
Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication
por: Eisig, Jaime N, et al.
Publicado: (2009) -
Comorbidities are Frequent in Patients with Gastroesophageal Reflux Disease in a Tertiary Health Care Hospital
por: Moraes-Filho, Joaquim Prado P, et al.
Publicado: (2009)